Agios Pharmaceuticals | Zobowiązania



Current Liabilities Zmiana Data
AbbVie USD 38.75B 4.31B 2024-12
Agios Pharmaceuticals USD 52.37M 28.79M 2025-03
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Amgen USD 23.01B 91M 2025-03
Arrowhead Research USD 220.54M 126.78M 2025-03
Astellas Pharma JPY 1.06T 90.95B 2025-03
AstraZeneca USD 29.13B 1.26B 2025-03
Bayer EUR 27.96B 993M 2025-03
Biogen USD 5.3B 231.4M 2025-03
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Daiichi Sankyo JPY 754.03B 41.68B 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Exelixis USD 399.1M 4.67M 2025-04
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 20.83B 866M 2025-03
Incyte USD 1.89B 244.96M 2025-03
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
Merck USD 25.17B 3.25B 2025-03
Moderna USD 1.6B 602M 2025-03
Novartis USD 28.69B 560M 2024-12
Novartis USD 28.69B 560M 2024-12
Pfizer USD 36.45B 6.54B 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



Agios Pharmaceuticals Zobowiązania - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.